2024 ASPC Congress on CVD Prevention

Here is what Michael Shapiro, DO, FASPC, ASPC president-elect, wants you to know about this year's meeting.

Click here to learn more about this year's ASPC Congress on CVD Prevention from ASPC President-Elect Michael Shapiro, DO, FASPC.
Continuing Medical Education
View All
July 21st 2024

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

June 27, 2024 | 1:00 PM & 7:00 PM ET
July 21st 2024

Supporting Safe, Effective, and Equitable Access to B-Cell Maturation Antigen (BCMA)-Directed Treatments in Multiple Myeloma: Strategies for Specialty and Managed Care Pharmacists

1.5 Credit / Hematology, Oncology
July 21st 2024

Empowering Pharmacists to Improve Care for Patients with Myelofibrosis

1.0 Credit / Oncology
July 21st 2024

Updates and Insights in Managing Anti-Androgen Therapies in Prostate Cancer

1.5 Credits / Oncology, Urology
July 21st 2024

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology
July 21st 2024

Optimizing the Utilization of Targeted Therapies in CLL: Considerations and Insights for the Managed Care Professional

1.5 Credit / Oncology
July 21st 2024

Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

1.0 Credit / Neurology
July 21st 2024

Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency

1.0 Credit / Pulmonology/Respiratory
July 21st 2024

Advances in the Treatment of Myelofibrosis: Updates and Considerations for Managed Care Professionals

1.0 Credit / Hematology, Oncology
July 21st 2024

The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression

July 31, 2024 | 1:00 PM & 8:00 PM ET
CH LogoCenter for Biosimilars Logo